运动对心力衰竭患者的流媒体扩张的影响:随机对照试验的系统审查和元分析
Yongjie Chen1,2, Bing Han2, Yifan Zhang2
1Beijing Key Laboratory of Sports Performance and Skill Assessment, Beijing Sport University, Beijing 100084, China.
Journal of cardiovascular development and disease
|December 24, 2025
概括
运动显著改善心力衰竭 (HF) 患者的血管功能. 在8周内经常进行较短时间的有氧运动,为高血压患者的血管流介导扩张 (FMD) 提供了最佳的益处.
科学领域:
- 心血管医学 心血管医学
- 运动生理学 运动生理学
- 康复科学 康复科学 康复科学
背景情况:
- 心力衰竭 (HF) 与血管功能受损有关,特别是减少流媒体扩张 (FMD).
- 运动干预对于管理高血压至关重要,但对血管健康的最佳方案仍在研究中.
研究的目的:
- 评估运动对患有心力衰竭 (HF) 的患者口炎的影响.
- 确定最有效的运动模型,以改善该群体的血管功能.
主要方法:
- 在主要数据库 (PubMed,Scopus,Web of Science,Embase,Cochrane) 进行了系统的文献搜索.
- 对11项研究 (224项干预,185名对照参与者) 进行了元分析,以评估运动对口腔炎的影响.
- 小组分析检查了不同的运动类型,持续时间,频率和干预期.
主要成果:
- 在HF患者中,运动显著改善了口病 (SMD = 1.14,p < 0.0001).
- 有氧运动显示出最大的疗效 (SMD = 1.25,p < 0.0001).
- 在干预时间 ≤8周,频率 >3次/周,持续时间 <每次60分钟的情况下,观察到最佳结果.
结论:
- 有氧运动是增强心力衰竭患者血管流媒介扩张的高效策略.
- 特定的运动参数:每周超过三次,每次不到60分钟,长达8周,与明显的口病改善有关.
- 这些发现为设计运动计划的临床医生提供了基于证据的指导,以改善HF人群的血管健康.
更多相关视频
相关概念视频
Heart Failure V: Medical Management
196
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
196
Heart Failure II: Pathophysiology
663
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
663
Exercise and Cardiovascular Response
3.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.8K
Exercise and Cardiac Output
1.8K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
1.8K
Heart Failure Drugs: β-Blockers
727
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
727
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
874
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
874


